(Q38128788)

English

Overview of food products and dietary constituents with antidiabetic properties and their putative mechanisms of action: a natural approach to complement pharmacotherapy in the management of diabetes

scientific article published on 14 August 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 August 2017

Overview of food products and dietary constituents with antidiabetic properties and their putative mechanisms of action: a natural approach to complement pharmacotherapy in the management of diabetes (English)

1 reference

Europe PubMed Central

29 August 2017

pharmacotherapy

0 references

author name string

Isabelle M E Lacroix

1

1 reference

Europe PubMed Central

29 August 2017

Eunice C Y Li-Chan

2

1 reference

Europe PubMed Central

29 August 2017

publication date

14 August 2013

1 reference

Europe PubMed Central

29 August 2017

Molecular Nutrition and Food Research

1 reference

Europe PubMed Central

29 August 2017

58

1 reference

Europe PubMed Central

29 August 2017

1

1 reference

Europe PubMed Central

29 August 2017

61-78

1 reference

Europe PubMed Central

29 August 2017

Global estimates of the prevalence of diabetes for 2010 and 2030

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Current antihyperglycemic treatment strategies for patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Pharmacogenetics of Anti-Diabetes Drugs

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Management of type 2 diabetes: new and future developments in treatment

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Oral antihyperglycemic therapy for type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Antidiabetic plants and their active constituents

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Dietary-resistant starch and glucose metabolism

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Environmental factors in the etiology of type 1 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Type 1 diabetes, the A1 milk hypothesis and vitamin D deficiency

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Skeletal muscle insulin resistance is the primary defect in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Meglitinide analogues in the treatment of type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Type 2 diabetes: principles of pathogenesis and therapy

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Clinical pharmacokinetics and pharmacodynamics of repaglinide

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Clinical pharmacokinetics of nateglinide: a rapidly-absorbed, short-acting insulinotropic agent

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Oral therapies for diabetic hyperglycemia

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Metformin Inhibits Hepatic Gluconeogenesis Through AMP-Activated Protein Kinase-Dependent Regulation of the Orphan Nuclear Receptor SHP

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Metformin: An Update

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Goals of treatment for type 2 diabetes: beta-cell preservation for glycemic control

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Effect of metformin on glucagon-like peptide 1 (GLP-1) and leptin levels in obese nondiabetic subjects

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Thiazolidinediones

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Direct demonstration of lipid sequestration as a mechanism by which rosiglitazone prevents fatty-acid-induced insulin resistance in the rat: comparison with metformin

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

alpha-Glucosidase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Diabetes and cardiovascular disease: the potential benefit of incretin-based therapies

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Glucagon-like peptide 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Therapeutic assessment of glucagon-like peptide-1 agonists compared with dipeptidyl peptidase IV inhibitors as potential antidiabetic drugs

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Neonatal exendin-4 prevents the development of diabetes in the intrauterine growth retarded rat.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

beta-cell failure in diabetes and preservation by clinical treatment

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Different modes of dipeptidyl peptidase IV (CD26) inhibition by oligopeptides derived from the N-terminus of HIV-1 Tat indicate at least two inhibitor binding sites

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Structural basis of proline-specific exopeptidase activity as observed in human dipeptidyl peptidase-IV

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Amylin analogues in the treatment of diabetes mellitus: medicinal chemistry and structural basis of its function

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Amylin agonists: a novel approach in the treatment of diabetes

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Diet-derived nutrients modulate the effects of amylin on c-Fos expression in the area postrema and on food intake.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Inhibition of food intake

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Bromocriptine mesylate: Food and Drug Administration approved new approach in therapy of non-insulin dependant diabetes mellitus with poor glycemic control

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Bromocriptine in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Bromocriptine: a sympatholytic, d2-dopamine agonist for the treatment of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Colesevelam hydrochloride for the treatment of type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Role of bile acid sequestrants in the treatment of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Role of bile acids and bile acid receptors in metabolic regulation

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Farnesoid X receptor is essential for normal glucose homeostasis

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Colestimide lowers plasma glucose levels and increases plasma glucagon-like PEPTIDE-1 (7-36) levels in patients with type 2 diabetes mellitus complicated by hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled study.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Dietary factors determining diabetes and impaired glucose tolerance. A 20-year follow-up of the Finnish and Dutch cohorts of the Seven Countries Study

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Fruit and vegetable consumption and diabetes mellitus incidence among U.S. adults

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Food consumption and the incidence of type II diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Whole grain, bran, and germ intake and risk of type 2 diabetes: a prospective cohort study and systematic review

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Associations of processed meat and unprocessed red meat intake with incident diabetes: the Strong Heart Family Study

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Dietary fat and meat intake in relation to risk of type 2 diabetes in men.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Processed meat intake and incidence of Type 2 diabetes in younger and middle-aged women

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Different polyphenolic components of soft fruits inhibit alpha-amylase and alpha-glucosidase.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Chemical composition and antioxidant/antidiabetic potential of Brazilian native fruits and commercial frozen pulps

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Functionality of bioactive compounds in Brazilian strawberry (Fragaria x ananassa Duch.) cultivars: evaluation of hyperglycemia and hypertension potential using in vitro models

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Antidiabetic effects of natural plant extracts via inhibition of carbohydrate hydrolysis enzymes with emphasis on pancreatic alpha amylase

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Inhibition of alpha-glucosidase and alpha-amylase by flavonoids

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Inhibition of alpha-glucosidase and amylase by luteolin, a flavonoid

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Luteolin, a flavone, does not suppress postprandial glucose absorption through an inhibition of alpha-glucosidase action

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Tannins: current knowledge of food sources, intake, bioavailability and biological effects.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Polyphenols and phenolic acids from strawberry and apple decrease glucose uptake and transport by human intestinal Caco-2 cells

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Inhibition of the intestinal glucose transporter GLUT2 by flavonoids.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Dietary polyphenols decrease glucose uptake by human intestinal Caco-2 cells.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

New hepatic targets for glycaemic control in diabetes

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Regulation of glucose production by the liver

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Acute inhibition of glucose-6-phosphate translocator activity leads to increased de novo lipogenesis and development of hepatic steatosis without affecting VLDL production in rats

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Chlorogenic acid and hydroxynitrobenzaldehyde: new inhibitors of hepatic glucose 6-phosphatase.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Contribution of chlorogenic acids to the inhibition of human hepatic glucose-6-phosphatase activity in vitro by Svetol, a standardized decaffeinated green coffee extract.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Coffee consumption and risk for type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Coffee consumption and risk of type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Dietary fibres, fibre analogues, and glucose tolerance: importance of viscosity

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Plant foods in the management of diabetes mellitus: spices as beneficial antidiabetic food adjuncts.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Gastric emptying of a solid meal is accelerated by the removal of dietary fibre naturally present in food

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

The effect on hunger and satiety of slowing the absorption of glucose: relationship with gastric emptying and postprandial blood glucose and insulin responses.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

The role of incretins in glucose homeostasis and diabetes treatment

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Resistant starch intakes in the United States

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Peptide YY and proglucagon mRNA expression patterns and regulation in the gut.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Effects of resistant starch, a non-digestible fermentable fiber, on reducing body fat.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Dietary lactitol fermentation increases circulating peptide YY and glucagon-like peptide-1 in rats and humans

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Fourteen weeks of treatment with Viscofiber increased fasting levels of glucagon-like peptide-1 and peptide-YY.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Adaptation of colonic fermentation and glucagon-like peptide-1 secretion with increased wheat fibre intake for 1 year in hyperinsulinaemic human subjects

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Meat hydrolysate and essential amino acid-induced glucagon-like peptide-1 secretion, in the human NCI-H716 enteroendocrine cell line, is regulated by extracellular signal-regulated kinase1/2 and p38 mitogen-activated protein kinases

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Casein and whey exert different effects on plasma amino acid profiles, gastrointestinal hormone secretion and appetite

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Dairy protein and leucine alter GLP-1 release and mRNA of genes involved in intestinal lipid metabolism in vitro

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

The corn protein, zein hydrolysate, administered into the ileum attenuates hyperglycemia via its dual action on glucagon-like peptide-1 secretion and dipeptidyl peptidase-IV activity in rats

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Are diprotin A (Ile-Pro-Ile) and diprotin B (Val-Pro-Leu) inhibitors or substrates of dipeptidyl peptidase IV?

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Tea contains potent inhibitors of tyrosine phosphatase PTP1B.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Protein tyrosine phosphatase 1B inhibitors for diabetes

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Tyrosine dephosphorylation and deactivation of insulin receptor substrate-1 by protein-tyrosine phosphatase 1B. Possible facilitation by the formation of a ternary complex with the Grb2 adaptor protein

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Mechanism of protein tyrosine phosphatase 1B-mediated inhibition of leptin signalling

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Regulation of PTP-1 and insulin receptor kinase by fractions from cinnamon: implications for cinnamon regulation of insulin signalling.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Nutraceuticals as Ligands of PPARγ

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Peroxisome proliferator-activated receptors: nuclear control of metabolism

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Structural basis for the activation of PPARgamma by oxidized fatty acids

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Potential health-modulating effects of isoflavones and metabolites via activation of PPAR and AhR.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Peroxisome proliferator-activated receptor gamma (PPARgamma ) as a molecular target for the soy phytoestrogen genistein

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Daidzein and the daidzein metabolite, equol, enhance adipocyte differentiation and PPARgamma transcriptional activity

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Identification of plant extracts with potential antidiabetic properties: effect on human peroxisome proliferator-activated receptor (PPAR), adipocyte differentiation and insulin-stimulated glucose uptake

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Anti-inflammatory properties of culinary herbs and spices that ameliorate the effects of metabolic syndrome

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Ginsenoside 20S-protopanaxatriol (PPT) activates peroxisome proliferator-activated receptor gamma (PPARgamma) in 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Novel PPAR-gamma agonists identified from a natural product library: a virtual screening, induced-fit docking and biological assay study

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Suppression of inducible cyclooxygenase and nitric oxide synthase through activation of peroxisome proliferator-activated receptor-gamma by flavonoids in mouse macrophages

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

A novel hydroxyfuroic acid compound as an insulin receptor activator. Structure and activity relationship of a prenylindole moiety to insulin receptor activation

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Identification of a molecular activator for insulin receptor with potent anti-diabetic effects

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Insulin-like biological activity of culinary and medicinal plant aqueous extracts in vitro.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Tea enhances insulin activity

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Isolation and characterization of polyphenol type-A polymers from cinnamon with insulin-like biological activity

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Insulin-mimetic action of conglutin-γ, a lupin seed protein, in mouse myoblasts.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Natural anti-diabetic compound 1,2,3,4,6-penta-O-galloyl-D-glucopyranose binds to insulin receptor and activates insulin-mediated glucose transport signaling pathway

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Does garlic have a role as an antidiabetic agent?

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Impact of dietary polyphenols on carbohydrate metabolism

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Insulin secretion by bioactive anthocyanins and anthocyanidins present in fruits.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Effects of garlic oil and diallyl trisulfide on glycemic control in diabetic rats

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Slow acting protein extract from fruit pulp of Momordica charantia with insulin secretagogue and insulinomimetic activities.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Oxidative stress and diabetic complications

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Antioxidant phytochemicals against type 2 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Role of nuclear factor (erythroid-derived 2)-like 2 in metabolic homeostasis and insulin action: A novel opportunity for diabetes treatment?

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Microarray and pathway analysis highlight Nrf2/ARE-mediated expression profiling by polyphenolic myricetin.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Dietary flavonols protect diabetic human lymphocytes against oxidative damage to DNA.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Oral Insulin-Mimetic Compounds That Act Independently of Insulin

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Discovery of a Small Molecule Insulin Mimetic with Antidiabetic Activity in Mice

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300223

21 January 2018

Identifiers

10.1002/MNFR.201300223

1 reference

Europe PubMed Central

29 August 2017

1 reference

Europe PubMed Central

29 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38128788&oldid=2129093491"